Login / Signup

Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.

Sofia K KonstantinidouGeorgia ArgyrakopoulouStamatia SimatiKonstantinos StefanakisAlexander KokkinosAntonis AnalitisChristos S Mantzoros
Published in: Diabetes, obesity & metabolism (2024)
Neither total nor H-specific GDF-15 levels are affected by Lira or N/B treatment in patients with overweight or obesity.
Keyphrases
  • weight loss
  • weight gain
  • metabolic syndrome
  • type diabetes
  • insulin resistance
  • physical activity
  • combination therapy
  • body mass index
  • skeletal muscle
  • smoking cessation